Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Bauman

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Current Opinion in Drug Discovery & Development|February 1, 2005
In vitro ADME phenotyping in drug discovery: current challenges and future solutionsJ Andrew Williams, Jonathan Bauman, Hongliang Cai, et al.
Current Drug Metabolism|December 20, 2003
Reaction phenotyping in drug discovery: moving forward with confidence?J Andrew Williams, Susan I Hurst, Jonathan Bauman, et al.
Journal of Medicinal Chemistry|January 5, 2018
Identification of Morpholino-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-ones as Nonsteroidal Mineralocorticoid AntagonistsDavid W Piotrowski, Kentaro Futatsugi, Agustin Casimiro-Garcia, et al.
Journal of Medicinal Chemistry|November 14, 2018
Identification of Cyanamide-Based Janus Kinase 3 (JAK3) Covalent InhibitorsAgustin Casimiro-Garcia, John I Trujillo, Felix Vajdos, et al.
Bioorganic & Medicinal Chemistry Letters|May 16, 2009
The discovery of novel calcium sensing receptor negative allosteric modulatorsGayatri Balan, Jonathan Bauman, Samit Bhattacharya, et al.
Journal of Medicinal Chemistry|November 2, 2022
Discovery of Ervogastat (PF-06865571): A Potent and Selective Inhibitor of Diacylglycerol Acyltransferase 2 for the Treatment of Non-alcoholic SteatohepatitisKentaro Futatsugi, Shawn Cabral, Daniel W Kung, et al.
ACS Chemical Biology|October 30, 2016
Discovery of a JAK3-Selective Inhibitor: Functional Differentiation of JAK3-Selective Inhibition over pan-JAK or JAK1-Selective InhibitionJean-Baptiste Telliez, Martin E Dowty, Lu Wang, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Current Opinion in Drug Discovery & Development|February 1, 2005
In vitro ADME phenotyping in drug discovery: current challenges and future solutionsJ Andrew Williams, Jonathan Bauman, Hongliang Cai, et al.
Current Drug Metabolism|December 20, 2003
Reaction phenotyping in drug discovery: moving forward with confidence?J Andrew Williams, Susan I Hurst, Jonathan Bauman, et al.
Journal of Medicinal Chemistry|January 5, 2018
Identification of Morpholino-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-ones as Nonsteroidal Mineralocorticoid AntagonistsDavid W Piotrowski, Kentaro Futatsugi, Agustin Casimiro-Garcia, et al.
Journal of Medicinal Chemistry|November 14, 2018
Identification of Cyanamide-Based Janus Kinase 3 (JAK3) Covalent InhibitorsAgustin Casimiro-Garcia, John I Trujillo, Felix Vajdos, et al.
Bioorganic & Medicinal Chemistry Letters|May 16, 2009
The discovery of novel calcium sensing receptor negative allosteric modulatorsGayatri Balan, Jonathan Bauman, Samit Bhattacharya, et al.
Journal of Medicinal Chemistry|November 2, 2022
Discovery of Ervogastat (PF-06865571): A Potent and Selective Inhibitor of Diacylglycerol Acyltransferase 2 for the Treatment of Non-alcoholic SteatohepatitisKentaro Futatsugi, Shawn Cabral, Daniel W Kung, et al.
ACS Chemical Biology|October 30, 2016
Discovery of a JAK3-Selective Inhibitor: Functional Differentiation of JAK3-Selective Inhibition over pan-JAK or JAK1-Selective InhibitionJean-Baptiste Telliez, Martin E Dowty, Lu Wang, et al.
Pageof 2